Central Laboratories Featured Articles

  1. 2024 CIO Survey Reveals IT Budgets, AI Priorities For Life Sciences Companies 4/9/2024

    Clarkston Consulting conducted its third annual Chief Information Officer (CIO) Survey to understand IT budgets of life sciences companies, how AI priorities fit into those budgets, and more.

  2. AI And Pharmaceutical Development: WHO Calls For Ethical Framework, Good Governance 4/8/2024

    The World Health Organization (WHO) recently released a document titled Benefits and risks of using artificial intelligence for pharmaceutical development and delivery describing the ethical issues and governance considerations for using AI in drug discovery, preclinical development, and clinical trials.

  3. Dear Data Analysts, AI Is Not Replacing You 4/2/2024

    Deep beneath the ongoing narrative of AI’s potential use cases in clinical trials is the same fear that persists in other industries facing a technology revolution. Will jobs be lost and replaced by machines? So, I thought I’d ask an expert — a machine.

  4. New FDA Draft Guidance: Data Monitoring Committees In Clinical Trials 4/1/2024

    In a new draft guidance, the FDA describes expectations of data monitoring committees in clinical trials. The public comment period ends April 15, 2024.

  5. A Structured Approach To Regulatory Information Management Vendor Selection 3/13/2024

    Deploying a formal system for regulatory information management is a given now for all life sciences companies, irrespective of their size and focus. Regulators expect this, particularly as data rather than static documents evolves to become the default.

  6. Best Practices For Complete Registration And Reporting Of Summary Results On ClinicalTrials.gov 3/5/2024

    The Clinical Trials Transformation Initiative (CTTI), alongside the FDA, investigated factors and barriers to registration and summary results information reporting. Here is what they found and what they suggest for ensuring complete reporting of trial results.

  7. Leveraging AI For Data Analysis In Pharmacy-Based Trials 2/28/2024

    Leveraging AI for data analysis in pharmacy-based trials holds immense potential for revolutionizing drug development and healthcare delivery.

  8. Making Rare Disease Progress With Novel Strategies, Data Standardization, And More 2/14/2024

    The integration of innovative research methodologies, coupled with the standardization of data and use of advanced visualization techniques, represents a holistic strategy to address the complexities of rare diseases.

  9. 9 Ways Unified Clinical Data Cloud Platforms Solve Data Challenges In Rare Disease 2/8/2024

    A unified clinical data cloud platform is a data and analytics platform that contains a data hub to aggregate clinical data from multiple data sources and in multiple formats — and it could be the cure for disordered rare disease data.

  10. It's Hard To Predict AI's Real Value To Clinical Trials 2/1/2024

    Sunny Kumar, a partner at GSR Ventures, plans to talk about AI and ML use in clinical trials during the SCOPE Summit panel, “The Future of Clinical Trial Tech: Perspectives from Different Investors.”